Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes
Usman et al., Journal of Thrombosis and Thrombolysis, doi:10.1007/s11239-022-02631-7
https://c19early.org/usman.html